1. Home
  2. BCO vs BLCO Comparison

BCO vs BLCO Comparison

Compare BCO & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCO
  • BLCO
  • Stock Information
  • Founded
  • BCO 1859
  • BLCO 1853
  • Country
  • BCO United States
  • BLCO Canada
  • Employees
  • BCO N/A
  • BLCO N/A
  • Industry
  • BCO Oil Refining/Marketing
  • BLCO Ophthalmic Goods
  • Sector
  • BCO Consumer Discretionary
  • BLCO Health Care
  • Exchange
  • BCO Nasdaq
  • BLCO Nasdaq
  • Market Cap
  • BCO 4.8B
  • BLCO 5.2B
  • IPO Year
  • BCO N/A
  • BLCO 2022
  • Fundamental
  • Price
  • BCO $111.50
  • BLCO $14.97
  • Analyst Decision
  • BCO Strong Buy
  • BLCO Hold
  • Analyst Count
  • BCO 1
  • BLCO 12
  • Target Price
  • BCO $138.00
  • BLCO $15.91
  • AVG Volume (30 Days)
  • BCO 183.9K
  • BLCO 490.9K
  • Earning Date
  • BCO 11-05-2025
  • BLCO 10-29-2025
  • Dividend Yield
  • BCO 0.92%
  • BLCO N/A
  • EPS Growth
  • BCO 24.94
  • BLCO N/A
  • EPS
  • BCO 3.72
  • BLCO N/A
  • Revenue
  • BCO $5,069,900,000.00
  • BLCO $4,891,000,000.00
  • Revenue This Year
  • BCO $5.33
  • BLCO $8.29
  • Revenue Next Year
  • BCO $4.60
  • BLCO $5.82
  • P/E Ratio
  • BCO $30.00
  • BLCO N/A
  • Revenue Growth
  • BCO 2.17
  • BLCO 8.81
  • 52 Week Low
  • BCO $80.10
  • BLCO $10.45
  • 52 Week High
  • BCO $118.60
  • BLCO $21.08
  • Technical
  • Relative Strength Index (RSI)
  • BCO 44.89
  • BLCO 53.23
  • Support Level
  • BCO $110.02
  • BLCO $14.67
  • Resistance Level
  • BCO $113.27
  • BLCO $15.31
  • Average True Range (ATR)
  • BCO 2.27
  • BLCO 0.45
  • MACD
  • BCO -0.73
  • BLCO -0.00
  • Stochastic Oscillator
  • BCO 20.05
  • BLCO 78.25

About BCO Brinks Company (The)

The Brink's Co is a provider of secure logistics and security solutions for cash and other valuables. Its segments include: North America segment includes operations in the U.S. and Canada, including the Brink's Global Services (BGS) line of business; Latin America segment consists operations in Latin American countries where it has an ownership interest, including the BGS line of business; Europe segment includes total operations in European countries that provide services outside of the BGS line of business; and Rest of World segment consists operations in the Middle East, Africa and Asia. It also includes total operations in European countries that provides BGS services and BGS activity in Latin American countries. It derives maximum revenue from North America segment.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: